Elizabeth Toy

Exeter, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UK.

Impact of the COVID-19 Pandemic on Outcomes for Patients with Lung Cancer Receiving Curative-intent Radiotherapy in the UK.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: March 17, 2023

Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK.

Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: July 16, 2021

Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer.

Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancer.

Journal: Nature

Published: September 05, 2020

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic.

Reduced Fractionation in Lung Cancer Patients Treated with Curative-intent Radiotherapy during the COVID-19 Pandemic.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: April 17, 2020

The National Lung Matrix Trial of personalized therapy in lung cancer.

The National Lung Matrix Trial of personalized therapy in lung cancer.

Journal: Nature

Published: January 28, 2020

The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.

The clinical role of VeriStrat testing in patients with advanced non-small cell lung cancer considered unfit for first-line platinum-based chemotherapy.

Journal: European journal of cancer (Oxford, England : 1990)

Published: May 02, 2019

Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres.

Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: August 14, 2017

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.

Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label, phase 3, randomised controlled trial.

Journal: The Lancet. Oncology

Published: February 09, 2016

Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.

Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.

Journal: The Cochrane database of systematic reviews

Published: January 15, 2015

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial.

Journal: The Lancet. Oncology

Published: October 20, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026